SAVAL Pharmaceuticals
SAVAL Pharmaceuticals is a Chilean-founded (1939) generic and branded pharmaceutical manufacturer with production plants in Chile and Costa Rica, distributing bioequivalent medications across 15 Latin American countries to physicians, pharmacies, hospitals, and patients through field sales and local distributors.
- Company typePrivate
- Founded1939
- HeadquartersRenca, Chile
- Headcount1,001–5,000
- GTM typeB2B
- OfferingHardware or Manufacturing
What SAVAL Pharmaceuticals does
SAVAL Pharmaceuticals (legal name Laboratorios SAVAL S.A.) is a privately-held Chilean pharmaceutical manufacturer founded in 1939, headquartered in Renca (Santiago de Chile) with a second production plant in Cartago, Costa Rica. The company manufactures and markets a portfolio of branded and bioequivalent (generic) pharmaceutical products spanning more than 80 therapeutic classes, including cardiovascular, antiinfective, central-nervous-system, respiratory, gastrointestinal, ophthalmology, dermatology, and supplement categories. Manufacturing operates under Good Manufacturing Practices (GMP) and Continuous Improvement, Total Quality, and World Class Manufacturing programs.
The company generates revenue through the sale of prescription and over-the-counter pharmaceutical products distributed via wholly-owned subsidiaries in Chile, Costa Rica, Panama, Peru, Bolivia, and Paraguay, supplemented by authorized distributor partnerships in Ecuador, Uruguay, Honduras, Haiti, Guatemala, El Salvador, the Dominican Republic, and Belize — covering 15 Latin American countries in total. Commercial operations rely on field-based medical representatives promoting to physicians and pharmacists, with product dispensing through retail pharmacies, institutional sales to hospitals and clinics, and a direct-to-patient digital coupon program (SAVAL Bienestar). The company also runs a Continuing Medical Education platform (EMC SAVAL) with 20+ years of activity serving more than 107,000 healthcare professionals across the region. Pricing is regulated and not publicly disclosed; a dedicated pharmacovigilance unit supports regulatory compliance and adverse-event reporting. Workforce size is stated at 1,001-5,000 employees (53% women, 47% men in Chile), with a Costa Rica plant and a regional distribution structure that anchors revenue diversification across multiple countries and therapeutic categories.
SAVAL Pharmaceuticals firmographics
Firmographics- Name
- SAVAL Pharmaceuticals
- Legal name
- Laboratorios SAVAL S.A.
- Website
- https://savalcorp.com
- Company type
- Private
- Founded year
- 1939
- Operating status
- Operating
- Headcount range
- 1,001–5,000 employees
- Short description
- SAVAL Pharmaceuticals is a Chilean-founded (1939) generic and branded pharmaceutical manufacturer with production plants in Chile and Costa Rica, distributing bioequivalent medications across 15 Latin American countries to physicians, pharmacies, hospitals, and patients through field sales and local distributors.
- Ownership category
- akta.pro rank
SAVAL Pharmaceuticals industry classification
Industry- Product category
- Generic Pharmaceuticals Manufacturing
- NAICS
- Pharmaceutical Preparation Manufacturing (325412), Drugs and Druggists' Sundries Merchant Wholesalers (424210)
- SIC
- Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
- akta.pro primary industry
- Specialty Care Pharmaceuticals (HLAIAAAB)
- akta.pro secondary industries
- Primary Care & General Medicine Pharmaceuticals (HLAIAAAA), Cardiology & Vascular Specialty Pharmaceuticals (HLAIACAG), Neurology & CNS Specialty Pharmaceuticals (HLAIACAC), Generic Hospital & Institutional Products (HLAIABAL)
Keywords
Where SAVAL Pharmaceuticals is headquartered
LocationHeadquarters
- HQ city
- Renca
- HQ country
- Chile
- HQ region
- Latin America
Offices17 records
Markets served
SAVAL Pharmaceuticals business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Operations, Personnel, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Pharmaceutical Product Sales: SAVAL generates revenue through the manufacture and sale of prescription and over-the-counter pharmaceutical products across 15 Latin American countries. Products are distributed through own subsidiaries and authorized distributors to pharmacies and healthcare institutions.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | Pay-as-you-go | Prescription and OTC pharmaceutical products across therapeutic categories |
Go-to-market motion1 record
Distribution channels4 records
Marketing channels6 records
SAVAL Pharmaceuticals product offering
Product offeringCore offering
SAVAL Pharmaceuticals (Laboratorios SAVAL S.A.) manufactures and distributes a bioequivalent pharmaceutical product portfolio covering cardiovascular, antiinfective, CNS, respiratory, gastrointestinal, ophthalmology, and dermatology therapeutic areas. Products are produced at GMP-certified plants in Chile and Costa Rica and commercialized across 15 Latin American countries through wholly-owned subsidiaries, authorized pharmaceutical distributors, and retail pharmacies, supported by a regional pharmacovigilance system and a long-running Continuing Medical Education program.
Product overview
SAVAL Pharmaceuticals is a Latin American pharmaceutical company with over 85 years of history, offering a comprehensive portfolio of prescription medications manufactured under strict quality and Good Manufacturing Practice (GMP) standards. The product portfolio includes branded pharmaceutical products across multiple therapeutic categories (analgesics, antibiotics, cardiovascular drugs, respiratory medications, gastrointestinal products, ophthalmics, CNS medications, and supplements), organized by commercial brand, active ingredient, and therapeutic class. The company also operates patient support programs (SAVAL Bienestar), pharmacovigilance services, and maintains production plants in Chile and Costa Rica with international distribution across 16 Latin American countries.
Differentiator
Problem solved
Functional benefit
Brands
- SAVALNET: Online portal for SAVAL products and services
- EMC SAVAL
- Centro SAVAL
- BIOMÉDICA SAVAL
- SAVAL Bienestar
- ARTE Y CULTURA SAVAL
- SAVAL Solidario
Products and services
- ZOMEL Antiulcerous prescription medication containing esomeprazole (proton pump inhibitor) indicated for gastroesophageal reflux disease (GERD), gastric ulcers, and H. pylori eradication.
- SOMNO XR Prolonged-release hypnotic prescription medication containing zolpidem tartrate for treatment of insomnia characterized by difficulty falling asleep and/or maintaining sleep.
- MENTANIA Cerebral vasodilator prescription medication containing standardized extracts of Ginkgo biloba and Panax ginseng, indicated for cerebral vascular insufficiency and cognitive deficit.
- OFTAVITA Polivitamin with minerals supplement containing vitamins A, C, E, B2, zinc, selenium, copper, manganese, and lutein/zeaxanthin for vitamin and mineral deficiency states.
- ALTAZINC Zinc supplement available in tablet and oral drops formulations for treatment and prevention of zinc deficiency states.
- Bioequivalent Products Portfolio Branded line of bioequivalent pharmaceutical products (ACTAN, ADAX, ALERTEX, ALEXIA/ALEXIA FORTE, ALIZON, AMINTA, AMOVAL, BLOX, CELTIUM, CIPROVAL, CLAVINEX DUO, CLIMAVAL, DRONAVAL, DUALTEN, ENALTEN, ETEROVAL, EUROCOR, EUROCOR D, EUROGESIC ADULTO, EUROGESIC ADULTO FORTE, EUROGREL, EUROMICINA, EUROVIR, FINEX, GESIX, IDON, LEOVAL, LIFTER, LUDIUM, LUKANEX, MIGTAL, MUXOL ADULTO, MUXOL PEDIÁTRICO, NICOL, NIRVAN, OBEXOL, PERTIUM, PROSTOP-D, QUETIUM, RIVOXA, RUX, SOMNO, TELLMI, TELLMI-D, VALAX, VENLAX, ZAFIN, ZIVAL, ZOMEL) demonstrating therapeutic equivalence to reference drugs.
- SAVAL Pharmacovigilance Service Dedicated pharmacovigilance unit that receives, records and notifies regulatory authorities about Adverse Drug Reactions (ADR) for SAVAL products. Includes reporting forms and a dedicated contact unit ([email protected]).
- SAVAL Bienestar Patient Program Patient wellness and discount program offering discount coupons on SAVAL products at participating pharmacies and health education content to improve patient access to medicines.
Quantifiable outcome
- Over 500 Continuing Medical Education courses delivered with 107,000+ students across 15 Latin American countries
- +2 more outcomes
Companies that use SAVAL Pharmaceuticals
Customer profileNamed customers16 records
Segments4 records
Ideal customer profiles3 records
SAVAL Pharmaceuticals technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
SAVAL Pharmaceuticals partnerships and signals
Strategic signalPartnerships
15 partnerships are on record, tiered core and minor.
- ECUAQUÍMICA C.A.coreECUAQUÍMICA C.A. serves as the authorized distributor of SAVAL pharmaceutical products in Ecuador, operating from offices in Quito and Guayaquil. Manager: Víctor Hugo Arias.
- CEFA Central Farmacéutica S.A.coreCEFA Central Farmacéutica S.A. is the authorized distributor of SAVAL products in Costa Rica, operating from the Pavas industrial zone. Manager: Juan Wong.
- SERVIMEDIC S.A.coreSERVIMEDIC S.A. is the authorized distributor of SAVAL products in Uruguay, based in Montevideo. Manager: José Cozza.
- Disfar SRLcoreDisfar SRL is the authorized distributor of SAVAL products in Paraguay, based in Asunción. Manager: Gustavo Bofill.
- World Pharmaceuticals - HASETH C.G. DE HASETH & CIA. S.A.coreWorld Pharmaceuticals (HASETH group) serves as the authorized distributor of SAVAL products in Panama, operating from Via Cincuentenario. Phone: +507 301-4000.
- EYL COMERCIAL S.A.coreEYL COMERCIAL S.A. is the authorized distributor of SAVAL products in Honduras, based in Tegucigalpa. Manager: Karenina Parada.
- SOPRODIS S.A.coreSOPRODIS S.A. is the authorized distributor of SAVAL products in Haiti, based in Port-au-Prince. Manager: Joseph Monestine.
- Centro Distribuidor S.A.coreCentro Distribuidor S.A. is the authorized distributor of SAVAL products in Guatemala, based in Guatemala City. Manager: Andrés Salas.
- Droguería Nueva San Carlos S.A. de C.V.coreDroguería Nueva San Carlos S.A. de C.V. is the authorized distributor of SAVAL products in El Salvador, based in Antiguo Cuscatlán, La Libertad. Contact: (503) 2212-7200.
- Doctores Mallen Guerra S.A.coreDoctores Mallen Guerra S.A. is the authorized distributor of SAVAL products in the Dominican Republic, based in Santo Domingo. Manager: Yennisse Alvarez.
- BIOMEDS LTDcoreBIOMEDS LTD is the authorized distributor of SAVAL products in Belize, based in Belmopan. Manager: Carlos Peraza.
- FARMAVAL Bolivia SRLcoreFARMAVAL Bolivia SRL is a subsidiary/distributor of SAVAL operating in Bolivia with offices in Santa Cruz, La Paz, and Cochabamba. Manager: Humberto Lillo.
- FARMAVAL Perú S.A.coreFARMAVAL Perú S.A. is a subsidiary/distributor of SAVAL operating in Peru, based in Lima. Manager: Jorge Bohorquez.
- Benemérito Cuerpo de Bomberos de Costa RicaminorStrategic partner of Laboratorios SAVAL Costa Rica. Firefighters conduct training activities in the company's facilities, provide training support for emergency teams, and supervise the fire prevention system annually.
- Fundación Hogar de Cristo, AMICAM, COAR, Fundación Nuestros Hijos (Chile)minorChile non-profit organizations receiving monetary and medicine donations from SAVAL as part of community CSR initiatives.
Scale indicators6 records
Recent moves6 records
Expansion highlights6 records
SAVAL Pharmaceuticals competitors and assessment
Company assessmentDirect peers
- Laboratorios Chile (Teva): Chilean pharmaceutical laboratory (now part of Teva) producing generic and branded pharmaceutical products in Chile and Latin America. Direct in-country competitor to SAVAL with overlapping therapeutic portfolio and Chilean manufacturing footprint.
- Grupo Insud: Argentine-Spanish pharmaceutical conglomerate producing generics and specialty branded products across Latin America. Comparable to SAVAL as a family-owned multi-country LatAm pharma manufacturer with bioequivalent portfolio.
- Genomma Lab Internacional: Mexico-based pharmaceutical company with broad portfolio of generic and OTC products across Latin America. Comparable to SAVAL in therapeutic breadth, bioequivalent positioning and pan-LatAm distribution across multiple countries.
- Mega Labs: Latin American pharmaceutical company headquartered in Uruguay with manufacturing and broad generic/specialty portfolio across multiple LatAm countries. Highly comparable to SAVAL in geographic footprint, therapeutic breadth and bioequivalent positioning.
- Tecnoquímicas: Colombian pharmaceutical company producing and distributing generics and branded pharmaceuticals across Latin America. Comparable to SAVAL as a regional generic manufacturer with manufacturing capacity and multi-country distribution in LatAm.
- Laboratorios Bagó: Argentine-founded multinational pharmaceutical company with generic and specialty branded products distributed across Latin America. Comparable to SAVAL as a regional generic/specialty manufacturer with multi-country presence and own manufacturing.
- Procaps Group: Colombian integrated pharmaceutical company with branded generics and softgel manufacturing capabilities serving Latin American markets. Comparable to SAVAL as a regional generic manufacturer with own production and multi-country presence.
- Eurofarma Laboratórios: Brazilian pharmaceutical company with broad generic and specialty portfolio and significant Latin American expansion. Comparable to SAVAL in broad therapeutic coverage, manufacturing scale and pan-LatAm go-to-market strategy.
Emerging players
- ABL Pharma: Latin American pharmaceutical company with branded generics in multiple therapeutic areas across Central and South America. Comparable to SAVAL as a regional generic manufacturer with cross-border distribution in Latin America.
Regional players
- EMS Pharma: Brazilian pharmaceutical manufacturer with broad generic and branded portfolio primarily serving Brazil. Comparable to SAVAL in therapeutic breadth and generic focus, though concentrated in Brazilian domestic market.
Market position
Strengths5 records
Weaknesses4 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
SAVAL Pharmaceuticals social profiles
Digital presenceSAVAL Pharmaceuticals compliance and trust
Trust signalCompliance2 records
SAVAL Pharmaceuticals financial estimates
Financial estimateRevenue estimate
Valuation estimate
SAVAL Pharmaceuticals leadership team
Management profileNumber of profiles
SAVAL Pharmaceuticals subsidiaries and ownership
Company hierarchySubsidiaries6 records
SAVAL Pharmaceuticals funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
SAVAL Pharmaceuticals M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about SAVAL Pharmaceuticals
What does SAVAL Pharmaceuticals do?
SAVAL Pharmaceuticals (Laboratorios SAVAL S.A.) manufactures and distributes a bioequivalent pharmaceutical product portfolio covering cardiovascular, antiinfective, CNS, respiratory, gastrointestinal, ophthalmology, and dermatology therapeutic areas. Products are produced at GMP-certified plants in Chile and Costa Rica and commercialized across 15 Latin American countries through wholly-owned subsidiaries, authorized pharmaceutical distributors, and retail pharmacies, supported by a regional pharmacovigilance system and a long-running Continuing Medical Education program.
Is SAVAL Pharmaceuticals a public or private company?
SAVAL Pharmaceuticals is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was SAVAL Pharmaceuticals founded?
SAVAL Pharmaceuticals was founded in 1939. It employs 1,001 to 5,000 people.
Where is SAVAL Pharmaceuticals based?
SAVAL Pharmaceuticals is headquartered in Renca, Chile, in the Latin America region.
How does SAVAL Pharmaceuticals make money?
One revenue line is on record: pharmaceutical Product Sales.
Who are SAVAL Pharmaceuticals's main competitors?
Direct peers on record are Laboratorios Chile (Teva), Grupo Insud, Genomma Lab Internacional, Mega Labs, Tecnoquímicas, Laboratorios Bagó, Procaps Group and Eurofarma Laboratórios. ABL Pharma is listed as an emerging player. EMS Pharma is listed as a regional player.
Does SAVAL Pharmaceuticals have an API?
No public API is recorded for SAVAL Pharmaceuticals.
What industry is SAVAL Pharmaceuticals in?
SAVAL Pharmaceuticals's product category is Generic Pharmaceuticals Manufacturing. Its primary akta.pro industry code is HLAIAAAB, Specialty Care Pharmaceuticals, with a secondary code of HLAIAAAA, Primary Care & General Medicine Pharmaceuticals. Its NAICS code is 325412 and its SIC code is 2834.